Timing of ctDNA Analysis Aimed at Guiding Adjuvant Treatment in Colorectal Cancer

Early ctDNA sampling is feasible and highly prognostic. Supplemental later testing may improve sensitivity while allowing early ACT initiation for most ctDNA-positive patients.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2025-02-20
DOI
https://doi.org/10.1158/1078-0432.ccr-24-3200
Citations
6
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
5.62

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Timing of ctDNA Analysis Aimed at Guiding Adjuvant Treatment in Colorectal Cancer

Per Vadgaard Andersen, Lene Hjerrild Iversen, Claudia Jaensch, Christina Demuth et al.
6 citations
Clinical Cancer Research
Cancer Genomics and Diagnostics
5.62
article

Timing of ctDNA Analysis Aimed at Guiding Adjuvant Treatment in Colorectal Cancer

Per Vadgaard Andersen, Lene Hjerrild Iversen, Claudia Jaensch, Christina Demuth, Tenna Vesterman Henriksen, Marijana Nesic, Mads H. Rasmussen, Uffe S. Løve, Nis H. Schlesinger, Claus L. Andersen, Thomas Kolbro, Amanda Frydendahl, Kåre Andersson Gotschalck, Alessio Monti, Ole H. Larsen, Jeppe Kildsig, Ole Thorlacius‐Ussing, Jesper Nors, Peter Bondeven
article en
6 citations

Abstract

Early ctDNA sampling is feasible and highly prognostic. Supplemental later testing may improve sensitivity while allowing early ACT initiation for most ctDNA-positive patients.

Clinical Cancer ResearchVol. 31(9)
Aarhus University (DK), Aalborg University Hospital (DK), Odense University Hospital (DK), Herlev Hospital (DK), Bispebjerg Hospital (DK), Aarhus University Hospital (DK), North Denmark Region (DK), Regionshospitalet Viborg (DK), Regional Hospital Horsens (DK), Nordic Lymphoma Group (DK), Regionshospitalet Herning (DK), Regional Hospital Randers (DK), Svendborg Sygehus (DK), Aalborg University (DK)
Kræftens Bekæmpelse, Lundbeckfonden, Dansk Kræftforsknings Fond, Direktør Emil C. Hertz og Hustru Inger Hertz Fond, Novo Nordisk Fonden, Fabrikant Einar Willumsens Mindelegat, KV Fonden, Knud og Edith Eriksens Mindefond
Good health and well-being
Openalex Percentile: Top 4%
Cancer Genomics and Diagnostics
5.62
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.